## AMT: American Tower Corporation (REI - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%); PEG 52.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($171.79)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. American Tower Corporation $AMT Stock Holdings Trimmed by State Street Corp**
- Source: MarketBeat | 20251209T131405 | Neutral | Relevance: 99%
-  State Street Corp reduced its stake in American Tower Corporation (NYSE:AMT) by 0.6% in the second quarter, ending with 21,113,680 shares valued at approximately $4.70 billion. Despite this, insider Eugene F. Reilly increased his holdings by purchasing 5,554 shares, and the company reported strong quarterly earnings, beating estimates with EPS of $2.78 and revenue of $2.72 billion. American Tower also declared a $1.70 quarterly dividend.

**2. Fayez Sarofim & Co Purchases 17,961 Shares of American Tower Corporation $AMT**
- Source: MarketBeat | 20251209T110818 | Somewhat-Bullish | Relevance: 98%
-  Fayez Sarofim & Co significantly increased its stake in American Tower Corporation (NYSE:AMT) by 52.8%, purchasing 17,961 additional shares, bringing their total holdings to 51,992 shares valued at approximately $11.49 million. This comes as American Tower reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $1.70 per share. Several other institutional investors have also adjusted their positions in American Tower, with 92.69% of the stock owned by institutional investors.

**3. London & Capital Asset Management Ltd Lowers Stock Holdings in American Tower Corporation $AMT**
- Source: MarketBeat | 20251209T130745 | Neutral | Relevance: 98%
-  London & Capital Asset Management Ltd significantly decreased its stake in American Tower Corporation (NYSE:AMT) by 60.8% in the second quarter, valuing its remaining 27,922 shares at $6.17 million. Despite this, other institutional investors like Blossom Wealth Management, TFG Advisers LLC, Novem Group, Analyst IMS Investment Management Services Ltd., and Marion Wealth Management increased their holdings in American Tower. The company recently reported strong quarterly earnings, beating analyst estimates, and announced a quarterly dividend of $1.70 per share, yielding 3.7%.

**4. Federated Hermes Inc. Buys 69,256 Shares of American Tower Corporation $AMT**
- Source: MarketBeat | 20251207T120732 | Bullish | Relevance: 98%
-  Federated Hermes Inc. increased its stake in American Tower Corporation by 12.4%, acquiring an additional 69,256 shares to hold a total of 625,945 shares valued at $138,346,000. Additionally, American Tower director Eugene F. Reilly purchased 5,554 shares, significantly increasing his ownership. The company also reported beating quarterly earnings estimates and declared a quarterly dividend of $1.70.

**5. Barclays turns cautious on American Tower (AMT) amid EchoStar risks**
- Source: MSN | 20251207T031420 | Neutral | Relevance: 97%
- Barclays has downgraded American Tower (AMT) to Equal Weight from Overweight, citing increased risks from the EchoStar (SATS) bankruptcy. Analyst Brandon Nispel believes the bankruptcy adds significant uncertainty for AMT, particularly regarding revenue and collections from DISH and EchoStar, and has adjusted his price target for American Tower to $193 from $226.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Morgan Stanley | $225 | $235 | -4% |
| 2025-12-01 | Barclays | $200 | $203 | -1% |
| 2025-11-17 | Barclays | $203 | $251 | -19% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Morgan Stanley | main | Overweight |
| 2025-12-01 | Barclays | down | Equal-Weight |
| 2025-11-17 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.99M) |
| Sells | 2 ($0.01M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.6% (+1.0%)
- Blackrock Inc.: 9.7% (-0.6%)
- JPMORGAN CHASE & CO: 6.6% (+142.8%)
- State Street Corpora: 4.5% (-0.9%)
- Cohen & Steers Inc.: 2.9% (-2.9%)

### Key Risks

1. Valuation stretched: PEG 52.8x requires aggressive growth execution.
2. Long-term trend broken: trading 12.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 52.79 signals overvaluation risk, limited margin of safety. Forward P/E 25.7x attractive for 37% earnings growth. Quality metrics strong (ROE 29%, margin 28%). Analyst sentiment negative (3 target cuts vs 0 raises). Insider buying signal ($1.0M), management confidence. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $84.1B |
| Beta | 0.92 |
| 52W Range | $172.51 - $234.33 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 52.79 |
| Forward P/E | 25.7 |
| Current P/E | 35.2 |
| YoY Growth | 36.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.7% to -0.5% (+3.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). Below SMA200 (0.88x), long-term trend not supportive. RSI neutral at 47.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.52% (CS: 53) | Neutral |
| RSI_14 | 47.1 | Neutral |
| MACD Histogram | 0.47 | Bullish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 0.977x | Below |
| vs SMA200 | 0.876x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $179.55
- **Stop Loss:** $171.79 (4.3% risk)
- **Target:** $187.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 64
- **Position Value:** $11,491.20
- **Portfolio %:** 11.49%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-24 (Est: $1.46)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.65 | $1.82 | +10.1% |
| 2025Q2 | $1.66 | $0.78 | -53.0% |
| 2025Q1 | $1.57 | $1.04 | -33.7% |
| 2024Q4 | $1.98 | $2.62 | +32.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*